Primary record
Risperidone; 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl- (9CI); 1,2-Benzisoxazole, 4H-pyrido[1,2-a]pyrimidin-4-one deriv.; R 64766; Risperdal; Spiron
- 库存
- 2,634 克
- 纯度
- 99.5 %
- CAS
- 106266-06-2
化合物标识与属性
- CAS
- 106266-06-2
- PubChem CID
- 5073
- SMILES
- CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
- Canonical SMILES
- Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
名称与同义词
- risperidone
- Risperdal
- Risperidal
- Rispolept
- Rispolin
- 106266-06-2
- Risperdal Consta
- Risperin
- Sequinan
- Risperidona
- Risperidonum
- Apexidone
- Risperidal M-Tab
- Spiron
- Risperdal M-Tab
- Psychodal
- Perseris
- Belivon
- risperdone
- Zophrenal
- Risperidonum [Latin]
- Consta, Risperdal
- buspirone
- ripedon
- Risperidona [Spanish]
- Risperidone-d4
- Respiridone
- Relday
- Rispen
- Okedi
- Risperdal;
- Risperdal (TN)
- Risperdal M
- RISVAN
- RYKINDO
- UZEDY
- Belivon;
- Risperidone CRS
- Risperidone-ISM
- Risperdal OD
- Risperdal quicklet
- Risperidone (RIS)
- Risperidone???
- Risperidone, placebo
- Risperidone M-tab
- RISPADAL
- Risperidone impurity K
- C23H27FN4O2
- L6UH7ZF8HC
- CHEMBL85
- PERSERIS KIT
- UNII-L6UH7ZF8HC
- RefChem:6202
- Risperidone (Standard)
- MFCD00274576
- RAPZEAPATHNIPO-UHFFFAOYSA-N
- Risperidone (Risperdal)
- DTXSID8045193
- Lopac-R-118
- AC1L1JJU
- RISPERIDONE [MI]
- Prestwick0_001029
- Prestwick1_001029
- Risperidone [USAN:BAN:INN]
- RISPERIDONE [INN]
- RISPERIDONE [JAN]
- RISPERIDONE [HSDB]
- RISPERIDONE [USAN]
- D01AZG
- GTPL96
- R 64 766
- RISPERIDONE [VANDF]
- N05AX08
- RCN3028
- CHEBI:8871
- RISPERIDONE [MART.]
- Risperidone(R 64 766)
- Risperdal Consta Long Acting
- Risperidone Impurity Standard
- SCHEMBL27911
- DTXCID6025193
- RISPERIDONE [USP-RS]
- RISPERIDONE [WHO-DD]
- HSDB 7580
- MLS000759429
- MLS001165758
- MLS001424081
- RCN-3028
- US8802672, Risperidone
- BIDD:GT0262
- NSC-759895
- R-64766
- SPBio_003078
- Risperidone (JAN/USAN/INN)
- Risperidone [USAN:INN:BAN]
- orb1310697
- PYR332
- SCHEMBL3146202
- Jsp000573
- R 64766
- Risperidone (JP18/USP/INN)
- Risperidone - Bio-X trade mark
- Risperidone [USAN:USP:INN:BAN]
- SCHEMBL29392548
- Risperidone, 1mg/ml in Methanol
- 106266-06-2 (free base)
- BRN 4891881
- CID5073
- R 64,766
- RISPERIDONE [EP IMPURITY]
- RISPERIDONE [ORANGE BOOK]
- GLXC-06632
- HMS1571M19
- HMS2051H07
- HMS2089C22
- HMS2098M19
- HMS2233O11
- HMS3373M18
- HMS3393H07
- HMS3657G13
- HMS3715M19
- HMS3753M15
- HMS3887G15
- HMS5087G17
- LY-03004
- Pharmakon1600-01506038
- RISPERIDONE [EP MONOGRAPH]
- RISPERIDONE [USP IMPURITY]
- Risperidone CRS (R1000600)
- ZINC538312
- RISPERIDONE [USP MONOGRAPH]
- ACT04270
- ALBB-038668
- BCP08161
- CID:5073
- KS-1106
- MSK10162
- Risperidone 1.0 mg/ml in Methanol
- THIOBIS(HEXAMETHYLDISILAZANE)
- Rykindo extended-release microspheres
- Tox21_110253
- ANW-42874
- BDBM50001885
- C23-H27-F-N4-O2
- CP-018
- CR0023
- EBC-13572
- HB1740
- HY-11018R
- NCGC00015883-05
- NP-202
- NP3200
- NSC759895
- NSC786035
- NSC801188
- R 64 766, Risperdal, Risperidone
- R-64,766
- R-64-766
- s1615
- STK646402
- AKOS005577302
- Risperidone for system suitability CRS
- Tox21_110253_1
- AC-1306
- CCG-100930
- CS-1619
- CS-O-02221
- DB00734
- FR27737
- LY03004
- NC00180
- NSC 759895
- NSC-786035
- NSC-801188
- PB26023
- Risperidone, >=98% (HPLC), powder
- RTR-001241
- R64766
- CAS-106266-06-2
- NCGC00015883-01
- NCGC00015883-02
- NCGC00015883-03
- NCGC00015883-04
- NCGC00015883-06
- NCGC00015883-07
- NCGC00015883-08
- NCGC00015883-11
- NCGC00094352-01
- NCGC00094352-02
- NCGC00094352-03
- NCGC00179257-01
- R-118
- AK172045
- AN-15065
- BC206675
- BR164349
- CPD000466323
- HY-11018
- R64,766
- SAM001246595
- SC-16313
- SID:53790689
- SMR000466323
- SY051250
- 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
- AB0004623
- J138.382E
- LS-134196
- TL8000230
- TR-001241
- A8514
- AB00514010
- EU-0101074
- FT-0631037
- FT-0674432
- NS00000033
- R0087
- SW197348-4
- KS-00000760
- 4767-EP2269990A1
- 4767-EP2272537A2
- 4767-EP2272841A1
- 4767-EP2275420A1
- 4767-EP2275423A1
- 4767-EP2280008A2
- 4767-EP2280010A2
- 4767-EP2298731A1
- 4767-EP2298776A1
- 4767-EP2301936A1
- 4767-EP2308867A2
- 4767-EP2308870A2
- 4767-EP2308875A1
- 4767-EP2316836A1
- 66R062
- A10797
- D00426
- EN300-117259
- J10290
- Q-4040
- R 62 766
- AB00514010-09
- AB00514010-11
- AB00514010-12
- AB00514010_13
- AB00514010_14
- A801409
- D018967
- L000510
- Q412443
- SR-01000075399
- 1-(2-Allyl-phenoxy)-3-isopropylamino-propan-2-ol
- I01-1156
- SR-01000075399-2
- SR-01000075399-8
- BRD-K53857191-001-04-5
- BRD-K53857191-001-10-2
- BRD-K53857191-001-21-9
- BRD-K53857191-001-22-7
- 3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
- 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
- 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
- 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-
- Z1501480428
- Risperidone, British Pharmacopoeia (BP) Reference Standard
- Risperidone, European Pharmacopoeia (EP) Reference Standard
- 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido [1,2-a] pyrimidin-4-one
- 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one
- 3-{2-[4-(6-FLUORO-BENZO[D]ISOXAZOL-3-YL)-PIPERIDIN-1-YL]-ETHYL}-2-METHYL-6,7,8,9-TETRAHYDRO-PYRIDO[1,2-A]PYRIMIDIN-4-ONE
- 4H-Pyrido(1,2-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl-
- Risperidone, United States Pharmacopeia (USP) Reference Standard
- 1020719-76-9
- 1026102-43-1
- 3-[2-[-4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one
- 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl}-6,7,8,9-tetrahydro-2-methylpyrido[1,2-a]pyrimidin-4-one
- 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
- 4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6 ,7,8,9-tetrahydro-2-methyl-
- 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-
- Risperidone, Pharmaceutical Secondary Standard; Certified Reference Material
- 3-Ethyl-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one(Risperidone Impurity)
- Risperidone for system suitability, European Pharmacopoeia (EP) Reference Standard
- Risperidone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
- (risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one
- 106266-09-5
- 2-(2-(4-(benzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-7,8,9,9a-tetrahydro-1H-pyrido[1,2-a]pyrimidin-4(6H)-one
- 2-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-6,7,8,8a-tetrahydro-5H-naphthalen-1-one
- 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one
- 3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidin-4-one
- 3-(2-(4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4H,6H,7H,8H,9H-pyrido(1,2-a)pyrimidin-4-one
- 3-(2-(4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido(2,1-b)pyrimidin-4-one
- 3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6 fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-fluoro- 1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidiny]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one
- 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-2,3,6,7,8,9-hexahydro-2-methyl-4H-Pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-Fluoro-1,2-benzoisoxazol-3-yl)piperidino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one
- 3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl}- 6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimid-in-4-one
- 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone)
- 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (risperidone)
- 3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one(risperidone)
- 3-{2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
- 4H-Pirido [1,2-a] pirimidina-4-ona, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-il)-1-] piperidinil etil]-6,7,8,9-tetrahidro-2-metil-
- 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benz-isoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-
- 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-methyl-1,3-dihydro-indol-2-one(Norastemizole)
- 8NU
- Risperidone, 99.5%, Dopamine, serotonin, adrenergic and histamine receptors antagonist - 250mg 250mg
- Risperidone; 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl- (9CI); 1,2-Benzisoxazole, 4H-pyrido[1,2-a]pyrimidin-4-one deriv.; R 64766; Risperdal; Spiron